Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Farnik

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Antiviral Therapy|May 26, 2012
New antiviral therapies in the management of HCV infectionHarald Farnik, Stefan Zeuzem
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2009
Optimal therapy in genotype 1 patientsHarald Farnik, Ulrike Mihm, Stefan Zeuzem
Endoscopy|July 20, 2016
Direct retrograde cholangioscopy with a new prototype double-bending cholangioscopeTorsten Beyna, Harald Farnik, Christoph Sarrazin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2010
Meta-analysis shows extended therapy improves response of patients with chronic hepatitis C virus genotype 1 infectionHarald Farnik, Christian M Lange, Christoph Sarrazin, et al.
Scandinavian Journal of Gastroenterology|November 12, 2014
Role of telaprevir plasma levels for predicting response to antiviral therapy in patients with hepatitis C virus genotype 1 infectionHarald Farnik, Nerea Ferreirós, Sandra Labocha, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 30, 2009
Highly sensitive determination of HCV protease inhibitors boceprevir (SCH 503034) and telaprevir (VX 950) in human plasma by LC-MS/MSHarald Farnik, Juliane El-Duweik, Christoph Welsch, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 7, 2009
Increased frequency of regulatory T cells and selection of highly potent CD62L+ cells during treatment of human lung transplant recipients with rapamycinChristian M Lange, Thuy Yen Vy Tran, Harald Farnik, et al.
European Journal of Gastroenterology & Hepatology|August 24, 2010
Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-α-2a and ribavirinChristian M Lange, Michael von Wagner, Jörg Bojunga, et al.
Endoscopy|December 20, 2013
A multicenter study on the role of direct retrograde cholangioscopy in patients with inconclusive endoscopic retrograde cholangiographyHarald Farnik, Jochen Weigt, Peter Malfertheiner, et al.
Journal of Hepatology|December 15, 2015
Lactic acidosis in patients with hepatitis C virus cirrhosis and combined ribavirin/sofosbuvir treatmentMartin-Walter Welker, Stefan Luhne, Christian M Lange, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Antiviral Therapy|May 26, 2012
New antiviral therapies in the management of HCV infectionHarald Farnik, Stefan Zeuzem
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2009
Optimal therapy in genotype 1 patientsHarald Farnik, Ulrike Mihm, Stefan Zeuzem
Endoscopy|July 20, 2016
Direct retrograde cholangioscopy with a new prototype double-bending cholangioscopeTorsten Beyna, Harald Farnik, Christoph Sarrazin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2010
Meta-analysis shows extended therapy improves response of patients with chronic hepatitis C virus genotype 1 infectionHarald Farnik, Christian M Lange, Christoph Sarrazin, et al.
Scandinavian Journal of Gastroenterology|November 12, 2014
Role of telaprevir plasma levels for predicting response to antiviral therapy in patients with hepatitis C virus genotype 1 infectionHarald Farnik, Nerea Ferreirós, Sandra Labocha, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 30, 2009
Highly sensitive determination of HCV protease inhibitors boceprevir (SCH 503034) and telaprevir (VX 950) in human plasma by LC-MS/MSHarald Farnik, Juliane El-Duweik, Christoph Welsch, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 7, 2009
Increased frequency of regulatory T cells and selection of highly potent CD62L+ cells during treatment of human lung transplant recipients with rapamycinChristian M Lange, Thuy Yen Vy Tran, Harald Farnik, et al.
European Journal of Gastroenterology & Hepatology|August 24, 2010
Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-α-2a and ribavirinChristian M Lange, Michael von Wagner, Jörg Bojunga, et al.
Endoscopy|December 20, 2013
A multicenter study on the role of direct retrograde cholangioscopy in patients with inconclusive endoscopic retrograde cholangiographyHarald Farnik, Jochen Weigt, Peter Malfertheiner, et al.
Journal of Hepatology|December 15, 2015
Lactic acidosis in patients with hepatitis C virus cirrhosis and combined ribavirin/sofosbuvir treatmentMartin-Walter Welker, Stefan Luhne, Christian M Lange, et al.
Pageof 2